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Abstract
Hyperthermia is known to be accompanied by considerable worsening of body oxygen delivery. Nitric oxide (NO)
is a messenger that contributes to the regulation of oxygen transport (vasodilation, formation of nitrosohemoglobin,
erythrocyte deformability), but also has cytotoxic effects (when abundantly generated by inducible NO synthase and
through a formation of peroxynitrite). The effects of NO synthesis inhibition on the blood oxygen transport
(hemoglobin-oxygen affinity and erythrocyte deformability) were investigated in rats with hyperthermia. The most
considerable changes in blood oxygen transport indices and the most pronounced hypoxia were observed in rats that
received the NO synthase inhibitor Nv-nitro-L-arginine methyl ester (L-NAME) i.p. Its administration before heating
significantly impaired body oxygen delivery, with a shift of the oxyhemoglobin dissociation curves rightwards and
lowering of erythrocyte deformability. The changes in the blood oxygen transport in animals receiving L-arginine and
L-NAME to prevent NO synthase inhibition were similar to those in rats treated with isotonic NaCl before heating.
© 1998 Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Hyperthermia was shown to be accompanied by
considerable worsening of body oxygen delivery
developing with involvement of mechanisms of
blood oxygen transport (Borisyuk and Zinchuk,
1995). Hemoglobin-oxygen affinity (HOA) is one
of important determinants of oxygen flux to tis-
sues (Khandelwal et al., 1993).
Nitric oxide (NO) has recently emerged as an
important messenger molecule which displays
multiple physiologic and pathophysiologic roles
(Moncada and Higgs, 1993). NO production is
catalyzed by the enzyme NO-synthase (NOS) dur-
ing the conversion of L-arginine to L-citrulline.
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The substrate for NO synthesis is L-arginine,
and some of its analogues have been used as
NOS blockers for the investigation of NO role,
for example, Nv-nitro-L-arginine methyl ester (L-
NAME) (Moncada and Higgs, 1993). NO is a
free radical produced by a variety of cell types
by the action of inducible and constitutive NOS.
NO is a potent vasodilator, and also possesses
a wide range of other actions, including antimi-
crobial, antiproliferative and anticoagulant ef-
fects. The increased production of NO, however,
has cytotoxic effects that appear to be partially
mediated by peroxynitrite, produced by the reac-
tion between NO and superoxide (Wink et al.,
1995). Peroxynitrite reacts with proteins to form
the stable product nitrotyrosine.
During hyperthermia the plasma levels of NO
metabolites increase (Carter et al., 1994; Hall et
al., 1994). Hemoglobin (Hb) plays an important
role in NO elimination from the body (Wen-
nmalm et al., 1993). The binding of oxygen to
heme irons in hemoglobin promotes the binding
of NO to cysteineb93 with formation of S-nitro-
sohemoglobin (a regulator of blood flow) (Stam-
ler et al., 1997). The effects of NO synthesis
inhibition at high temperature and the associ-
ated changes of blood oxygen transport have
been unclear. Therefore, it seemed important to
investigate the effect of NO synthesis inhibition
on blood oxygen-carrying function during hyper-
thermia.
2. Methods
2.1. Experimental protocol
The experiment was carried out in male labo-
ratory rats (body weight 190–230 g) maintained
in a vivarium at 20°C. The animals were divided
into five groups (n6 in each): group 1, control
(receiving isotonic solution of NaCl i.p.); group
2 received NOS inhibitor Nv-nitro-L-arginine
methyl ester (L-NAME) i.p. (Sigma, St. Louis,
MO). The other three groups were exposed to
heat immediately after being treated with: group
3, isotonic solution of NaCl i.p.; group 4, L-
NAME i.p.; group 5, L-arginine (Sigma) and L-
NAME i.p. to prevent the inhibition of NOS.
The drugs were administered as a single dose in
1 ml of the solution (L-NAME 25 mg:kg, L-
arginine 600 mg:kg). The animals were exposed
to heating by hot air (40°C) in a thermal cham-
ber for 60 min. The rectal temperature was mea-
sured by an electric thermometer. Blood was
taken from the right atrium on the 60th min
after the start of heat treatment under ether
anesthesia.
2.2. Measurement of hemoglobin-oxygen affinity
PO2 and acid–base balance were measured by
a micro gas analyser (ABL-330, Radiometer)
under 37°C and then were corrected to the ac-
tual temperature value. Blood oxygen content
(CvO2) was evaluated by a rise of PO2 in a blood
aliquot after the oxygen release from a complex
with Hb by 0.33% potassium ferrocyanide
(Volter and Herigault, 1972); the percent of
hemoglobin saturation by oxygen (SO2) was cal-
culated. HOA was assessed by P50 (blood PO2
under its 50% saturation by O2) as determined
by a ‘mixing method’ (Scheid and Meyer, 1978)
at 37°C, pH 7.4 and PCO240 Torr (P50st). The
values of P50 at actual pH, PCO2 and tempera-
ture (P50act) were calculated from P50st by
Severinghaus equations (Severinghaus, 1966) and
with the temperature coefficient DLgP50:DT
0.024 (Willford et al., 1982); the oxyhemoglobin
dissociation curves (ODC) were calculated ac-
cording to Hill’s equation with n2.8 from the
measured P50.
2.3. Measurement of red blood cell deformability
The erythrocyte deformability (ED) was mea-
sured by ektacytometry, based on a determina-
tion of deformability index from the diffraction
pattern after the transmission of monochromatic
coherent light (l850 nm) through a laminary
flow of a red cell suspension under thermostate
conditions (Hochmuth, 1993). The decrease of
deformability index reflects an impairment of
red cells deformability.Ре
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Table 1
Effect of L-NAME on hematological and blood gas parameters during hyperthermia in rats
L-NAME Hyperthermia HyperthermiaControl HyperthermiaL-arginineParameter
L-NAME L-NAME
pH 7.32690.007 7.31690.016 7.29590.007* 7.28090.11* 7.29290.011*
7.29590.015 7.25690.008*7.30990.007 7.23290.012*pHact 7.24890.010*
47.6594.47PCO2 (Torr) 47.1596.31 41.290.95 37.1592.08* 39.7792.11
50.0396.68PCO2act (Torr) 46.2791.0850.1294.65 42.7492.41 45.1992.30
27.5391.53 23.6791.41*29.0291.72 19.8391.54*PO2 (Torr) 20.0291.64*
30.3691.72 28.6091.73PO2act (Torr) 24.95924.95*31.5591.92 24.6792.01*
37.990.50 33.2690.61*35.6690.65 40.7090.93*P50stand (Torr) 33.7190.34*
34.9490.73P50act (Torr) 37.3791.18 34.0390.44 42.3291.19* 35.2590.65
12.290.19 12.190.2512.6390.17 12.5590.28Hb (g:dl) 12.8790.23
8.4190.29CvO2 (ml:dl) 3.7191.28 5.9390.27 5.5290.50 6.3290.29
43.291.56SO2 (%) 36.6891.16*49.0091.44 32.4893.07* 37.9492.70*
23.8990.42 19.7390.77*25.2890.52 17.0590.24*HCO3
 (mmol:l) 18.9890.92*
2.390.59 5.5390.96*ABE (mmol:l) 8.7890.50*1.4390.53 6.0891.07*
22.7890.58 19.4190.76*23.7390.99 18.4790.46*SBC (mmol:l) 19.5291.26*
25.0890.43tCO2 (mmol:l) 20.6990.77*26.1490.57 19.190.27* 20.7891.25*
38.0590.13 38.0890.0838.0390.12 38.1590.08Trect (0 min) (°C) 38.2890.05
38.370.12Trect (60 min) (°C) 39.650.14*38.1790.10 40.290.20* 39.9390.12 *
Values are mean9SD. n6 for each group.
* Statistically significant difference from control (PB0.05).
2.4. Statistic methods
The data were statistically evaluated by Stu-
dent’s t-test with a significance level of PB0.05.
The correlations were obtained from the least-
squares linear regression analysis. The results are
presented as means9SE. The analysis and graphs
were performed using computer software pack-
ages (version 3.0, Statgraphics; version 4.0,
QUATROPRO).
3. Results
The blood oxygen-carrying function had some
changes in the investigated rats (Table 1). The
high temperature brought about a development of
metabolic acidosis accompanied by moderate hy-
percapnia (7.29590.007, PB0.05 vs. 7.3269
0.07 in control); the actual and standard base
excesses were significantly lower. The oxygen de-
livery had also worsened (PO2 decreased from
29.0291.72 to 23.67 (PB0.05) and SO2 from
49.0091.44 to 36.791.16 (PB0.01). The admin-
istration of L-NAME alone to control animals did
not significantly affect the indices of acid–base
balance and blood oxygen transport, despite
somewhat lowered PO2, SO2, and CvO2. The
metabolic acidosis was most severe in L-NAME
pretreated hyperthermic rats (pH7.28090.11;
after the correction for temperature the lowering
of pH was even more significant (to 7.23290.012
(PB0.01) vs. 7.30990.07 in control rats). The
hypoxic signs were more marked (PO219.839
1.54, PB0.01; SO232.4893.07, PB0.01). The
heating after the L-arginine and L-NAME pre-
treatment was accompanied by a change in the
acid–base balance and oxygen state towards their
values in group 2. The heated animals pretreated
with L-NAME had the highest temperature rise
(by 2.0590.19°C).
In rats which received L-NAME before heating,
the value of P50act was 42.3291.2 Torr vs.
34.990.73 in control (PB0.01), indicating a shiftРе
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Fig. 1. Actual oxyhemoglobin dissociation curves in control
(triangle) and heated rats with inhibition of NO synthase
(filled square).
The ED worsened during heat exposure (Fig.
2). Its decrease was most marked under NOS
inhibition (0.23590.018 vs. 0.30890.07 in con-
trol; PB0.01), while the heating of intact rats
resulted in ED0.25690.013 (PB0.01).
4. Discussion
The results indicate that administration of NOS
inhibitor L-NAME before the heating significantly
worsened body oxygen delivery, with a shift of
ODC rightwards and lowering of ED. The
changes in blood oxygen transport in the animals,
receiving L-arginine and L-NAME to prevent
NOS inhibition, were similar to those in rats
receiving isotonic NaCl before the heating.
The exposure to high temperature caused an
enhancement of the NO production by the body,
as determined by the urinary excretion of nitrate
(Carter et al., 1994) and the NO-heme electronic
paramagnetic resonance signal (Hall et al., 1994);
this is undoubtedly important for enhancement of
body heat losses; but the excessive NO formation
may cause toxic effects. Recent investigations in-
dicated an important role of NO and peroxyni-
trite (the product of its interaction with
superoxide anion) in cellular damage (Wink et al.,
1995). In the present study the effect of NO on
the thermoregulatory vasodilation was negligible
because the environment had a higher tempera-
ture than the body, but its effect on the vapora-
tive heat loss might be considerable. The NOS
inhibition decreased the thermolytic salivation in
rats during heating (Damas, 1994). Therefore, the
restriction of NO synthesis by a constitutive
isoenzyme of NOS is important for maintaining
of temperature homeostasis and vascular tone.
NO produced by endothelial cells maintains a
vasodilation and hence the blood flow at the
optimal level for tissue oxygenation. The constitu-
tive isoform of NOS is sensitive to low PO2, and
hypoxia increases the expression of mRNA of this
isoform (Xu et al., 1995). The inhibition of NO
synthesis in intact dogs lowered the oxygen deliv-
ery (Cobb et al., 1995) and simultaneously in-
creased the mean arterial pressure and systemic
and pulmonary vascular resistance. The reduction
of actual ODC rightwards (Fig. 1). The corre-
sponding values of P50st were 40.7090.93 vs.
33.9191.10 Torr in control (PB0.01). The val-
ues of P50st and P50act during hyperthermia in
rats of group 3 (33.2690.61 and 34.0390.44
Torr) and group 5 (33.7190.34 and 35.2590.65
Torr) were very similar, but the administration of
L-NAME alone without heating resulted in a rise
of P50st to 37.990.50 Torr.
Fig. 2. Index of erythrocyte deformability in rats under NO
synthase inhibition during hyperthermia. Mean values9SE
are shown; significant differences from the control group are
marked with asterisks (*).Ре
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of the blood flow during the blockade of NO
synthesis resulted in a decrease of skeletal muscle
tissue PO2 from 29 to 11 Torr after 30 min (Pohl
et al., 1993). The ability of endothelium to active
synthesis of NO was suggested to play a key role
in the optimization of oxygen delivery and oxygen
demands both at rest and during a load (Wagner
et al., 1992). Impairment of NO synthesis by the
endothelium largely explains a loss of vasocon-
strictory regulation by means of a lower adapta-
tion of the blood flow to the tissue demands,
which was observed during the functional and
reactive hyperemia after NO synthesis inhibition
(Kostic and Schrader, 1992).
The shift of ODC rightwards is generally con-
sidered to rise an oxygen unloading to tissues. The
decrease of HOA is both an important compensa-
tory factor for oxygen insufficiency under differ-
ent pathologic conditions and a mechanism of
adaptation to the oxygen insufficiency. In experi-
ments in rats, the rise of P50 by 25% was accom-
panied by an average increase of tissue PO2 by
78% (Khandelwal et al., 1993). The higher than
normal value of P50 appears to be favourable for
optimal oxygen transport to tissues under nor-
moxia or moderate hypoxia (Willford et al.,
1982).
During body hyperthermia, the ODC position
is largely determined by temperature and pH and
to a lesser extent by PCO2 (Borisyuk and Zinchuk,
1995). The actual position of ODC is a result of
cumulative action of these non-unidirectional fac-
tors. The temperature is the most significant fac-
tor influencing on HOA. The absence of
correction by 1°C during the measurements of PO2
and PCO2 can lead to an 11% error in calculated
fraction of arteriovenous shunt (Siggaard-An-
dersen and Siggaard-Andersen, 1995). Wood
(1980) indicated two possible ways to change the
temperature effect on HOA in the whole body—
through a switching of the heterogenous system of
Hb synthesis or through the mechanism of al-
losteric interaction. The first way may be based on
the synthesis of completely thermotolerant Hbs or
Hbs with a weaker temperature-dependent co-op-
erative interaction with oxygen. However, such a
way with a morphogenetic change in the synthesis
of different Hbs cannot be manifested during
relatively short adaptation to temperature. The
adaptive change of blood oxygen-binding proper-
ties is essentially caused by a relatively au-
tonomous intraerythrocyte system of HOA
regulation. Red cell 2,3-diphosphoglycerate func-
tions as a trigger of allosteric regulation of glycol-
ysis and as a specific reference device for an
agreement between the metabolic and functional
states. This organic phosphate is known to exert a
profound effect on HOA, which can increase the
blood P50 by 50% (Benesch and Benesch, 1970).
The investigation of the 2,3-diphosphoglycerate
content in mixed venous red blood cells of heated
rabbits had shown its drop by 40% at the end of
the heating and during the first 4 h after it
(Borisyuk and Zinchuk, 1995). The changes in
HOA during hyperthermia combined with the
inhibition of NO synthesis do not contribute to
the elimination of oxygen deficiency.
Hb plays a very important role in the elimina-
tion of NO from the body. In arterial blood NO
is inactivated in a reaction with oxyhemoglobin to
yield nitrate and methemoglobin, and in addition
to these products, nitrosohemoglobin is also gen-
erated in venous blood (Wennmalm et al., 1993);
under high PO2 it may be disintegrated by O2 to
Hb and NO3. High doses of the NO donor
nitroglycerine cause a formation of nitroso-
hemoglobin, with the concentration correlating
with the P50 value and the corresponding ODC
shift rightwards (Kosaka and Seiyama, 1996). By
thus sensing the physiological oxygen gradient in
tissues, hemoglobin exploits conformation-associ-
ated changes in the position of cysteineb93-S-NO
to bring the local blood flow into line with the
oxygen requirements (Stamler et al., 1997). In
these experiments, the shift of ODC rightwards
cannot compensate for the insufficiency of blood
flow under hyperthermia combined with NOS in-
hibition. At earlier stages of heating L-NAME
firstly inhibits endothelial rather than inducible
NOS, as in the case of fever (Redford et al.,
1995), and this inhibition plays a key role in a
genesis of developing hypoxia. The limitation of
NO synthesis under conditions of lowered en-
dothelial and increase inducible NOS activities
may cause a positive effect at later stages of
hyperthermia and be accompanied by less marked
disturbances in blood oxygen transport.Ре
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When the NO synthesis was inhibited, the ery-
throcyte rigidity enhanced most markedly. The
treatment of red blood cells by competitive L-
arginine analogues lowered the hypotonic hemoly-
sis, increased the input of K, and the spinal
changes of erythrocyte morphology (Caramelo et
al., 1994). The reduction of ED is not adaptive
and reflects a failure in the compensatory abilities
of oxygen transport mechanisms. The worsening
of deformability is the highest under conditions of
the most marked hypoxia (judged by the indices
of acid–base balance and blood oxygen trans-
port). The observed worsening of ED restricts the
oxygen transport to tissues via different mecha-
nisms: lowering of intraerythrocyte convection,
changes in Fahreus–Lindqvist effect, increases in
the arteriovenous shunt and in the whole blood
viscosity.
Thus, the results have shown that the inhibition
of NOS during hyperthermia results in a more
significant impairment of body oxygen supply,
with important roles of HOA and ED in its
mechanisms. Pretreatment with excessive L-
arginine prevented the inhibition of NO synthesis
and was accompanied by development of a typical
response to high temperature and less marked
alterations in blood oxygen transport.
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